Compare Cassava Sciences Inc (FLNA) vs Global X Defense Tech ETF (SHLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Global X Defense Tech ETF — how do they compare? Cassava Sciences Inc trades at $1.06 (market cap $53.14M), while Global X Defense Tech ETF trades at $59.69. Which is the better fit depends on your goals.
| FLNA | SHLD | |
|---|---|---|
Market Cap | $53.14M | — |
Sector | Health | Sector/Thematic |
52-Week High | $4.64 | $78.02 |
52-Week Low | $1.09 | $58.20 |
Enterprise Value | -$33.43M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
SHLD, the Global X Defense Tech ETF, trades at $59.85, down 0.61% on the day amid a bearish technical signal. The ETF offers exposure to global defense companies, with recent news highlighting its role in the rearmament cycle and comparisons to peers like XAR and ITA. Key support sits at $59, while resistance is at $61. Financial ratios are not applicable as this is an ETF tracking a basket of stocks.
Outlook is supported by rising global defense spending but tempered by competition from other defense ETFs and bearish technical indicators. Risks include geopolitical shifts and expense ratio comparisons. The neutral sentiment from oscillators suggests a wait-and-see approach may be prudent for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Global X Defense Tech ETF
SHLD tracks the Global X Defense Tech Index, targeting companies that lead the technological transformation of the defense sector. It focuses on pure-play innovators in cybersecurity, artificial intelligence, robotics, and advanced military systems, excluding traditional commercial aerospace to maintain a high level of thematic purity.
Read more on SHLD →
